top of page
  • Writer's pictureatharva hingane

General Anaesthetics Market, Global Outlook and Forecast 2023-2030

The global General Anaesthetics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.


The USA market for Global General Anaesthetics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-general-anaesthetics-forecast-2023-2030-151



The China market for Global General Anaesthetics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.


The Europe market for Global General Anaesthetics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.


General Anesthesia Drugs, also known as general anaesthetics, is a kind of drug that can inhibit the central nervous system function, make the consciousness, feeling and reflection temporarily disappeared, skeletal muscle relaxation, mainly used for anesthesia before surgery.

This report aims to provide a comprehensive presentation of the global market for General Anaesthetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anaesthetics. This report contains market size and forecasts of General Anaesthetics in global, including the following market information:


  • Global General Anaesthetics Market Revenue, 2018-2023, 2024-2030, ($ millions)

  • Global top five companies in 2022 (%)


The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.

by Drug Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of General Anaesthetics include Astrazeneca, Fresenius-Kabi, Abbott, Bayer, AbbVie, Baxter Healthcare, B.Braun, Maruishi and Piramal, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the General Anaesthetics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global General Anaesthetics Market, by Type, 2018-2023, 2024-2030 ($ millions)

Global General Anaesthetics Market Segment Percentages, by Type, 2022 (%)


  • by Drug Type

  • Propofol

  • Sevoflurane

  • Etomidate

  • Midazolam

  • Isoflurane

  • Other

  • by Delivery Drug Way

  • Intravenous Anesthetics

  • Inhalational Anesthetics


Global General Anaesthetics Market, by Application, 2018-2023, 2024-2030 ($ millions)

Global General Anaesthetics Market Segment Percentages, by Application, 2022 (%)


  • Emergency Room

  • Operating Room

  • ICU

  • Surgical

  • Oncology


Global General Anaesthetics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)

Global General Anaesthetics Market Segment Percentages, By Region and Country, 2022 (%)


  • North America (United States, Canada, Mexico)

  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)

  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)

  • The Middle East and Africa (Middle East, Africa)

  • South and Central America (Brazil, Argentina, Rest of SCA)


Competitor Analysis

The report also provides analysis of leading market participants including:


  • Key companies General Anaesthetics revenues in global market, 2018-2023 (estimated), ($ millions)

  • Key companies General Anaesthetics revenues share in global market, 2022 (%)


Further, the report presents profiles of competitors in the market, key players include:


  • Astrazeneca

  • Fresenius-Kabi

  • Abbott

  • Bayer

  • AbbVie

  • Baxter Healthcare

  • B.Braun

  • Maruishi

  • Piramal

  • Hikma Pharmaceuticals

  • Mylan

  • Lunan

  • Humanwell Healthcare

  • Nhwa Pharmaceutical

  • Guangdong Jiabo Pharmaceutical

  • Sichuan Guorui Pharmaceutical

  • Xi'an Libang Pharmaceutical

  • Sichuan Kelun Pharmaceutical

  • Hengrui Pharmaceutical

  • Shanghai United Imaging Healthcare

  • Wandong Medical Technology


Outline of Major Chapters:

Chapter 1: Introduces the definition of General Anaesthetics, market overview.

Chapter 2: Global General Anaesthetics market size in revenue.

Chapter 3: Detailed analysis of General Anaesthetics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of General Anaesthetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

CONTACT US:

276 5th Avenue, New York , NY 10001,United States

International: (+1) 646 781 7170

0 views0 comments

Recent Posts

See All

Commentaires


bottom of page